PwC’s Global 100 Software Leaders driven by three key trends
NEW YORK, 2016-06-22 15:45 CEST (GLOBE NEWSWIRE) -- PwC’s new Global 100 Software Leaders ranking illustrates a rapidly shifting landscape and reveals three key trends among companies that are taking advantage of both evolutionary and revolutionary changes in the software industry.
An infographic accompanying this announcement is available at: http://www.globenewswire.com/NewsRoom/AttachmentNg/6f6437d7-3fd2-429d-a595-d4476a0986bb
Within this shifting environment, the interwoven trends of digital innovation, Industry 4.0 and convergence are driving opportunities to create smarter, leaner and better software. As these trends fuel the industry, we’re seeing an increasing number of startups coming to the forefront, adding to the challenges facing legacy software vendors and their customers.
The three key themes weigh heavily on PwC’s overarching research findings:
- The software industry is experiencing a rapid expansion of its total addressable market (TAM) and a high level of turbulence.
- Cloud adoption is creating new software-as-a-service (SaaS)-based business models.
- The move to SaaS significantly impacts the revenue of traditional vendors.
- Connected devices and artificial intelligence are creating new business opportunities.
“Everywhere we look, software is defining what products do, and it’s redefining how companies are categorised,” said Raman Chitkara, PwC’s Global Technology leader. “Analysing the changes between the new Global 100 Software Leaders and the previous ranking from 2014 indicates just how dynamic the market is—and will continue to be.”
Fourteen companies fell off the current list since the 2014 ranking, and 10 of the previous bottom 12 are gone. “Several companies couldn’t keep up their growth and, as a result, fell off the list,” says Mark McCaffrey, PwC Global Software Leader. “There are others that are large enough to survive because they have the cash and the wherewithal to acquire cloud companies.”
Key trend #1: Digital innovation
Startups are propelling much of the dynamic creativity in the software industry, and they are using the new world of technology as a blank canvas for software applications across industries.
Thanks to mobility and the cloud, software can now be consumed anywhere—and innovation can happen anywhere. But globalisation can be a double-edged sword when it comes to innovation. Government regulations, such as the European Union’s Safe Harbour rules governing data privacy, can create confusion, and regional companies in emerging markets can face scalability issues when it comes time to compete against companies launched from larger markets.
Established software companies are not standing still on cloud-based customer options. The top four companies on PwC’s list all made recent significant cloud acquisitions.
Key trend #2: Industry 4.0
Cloud continues to drive new capabilities in the Internet of Things (IoT) through the proliferation of devices, sensors and remote or mobile objects that automatically transmit information. In addition to a cloud-based data repository, intelligent device software also requires the ability to transmit and analyse data.
The cloud provides enterprises with a great deal of flexibility. SaaS vendors appreciate the efficiency they get from hosting software. For instance, all customers will be running the same software version. When it’s time to upgrade, they only need to change it once in their system rather than in each user’s system. Cloud adoption is accelerating but has not yet reached the tipping point. While users’ comfort with cloud is growing across the globe, there remains some lingering doubt related to security and 24/7 accessibility. In response, software companies are expected to increase investments for maintaining the security, reliability and 24/7 accessibility of their products and services.
Key trend #3: Convergence
Software is becoming more prevalent in more places, and this affects the revenues of major industry verticals, including financial services, healthcare, manufacturing and retail.
- Financial services – The banking industry is working hard to accommodate new digital and mobile payment systems, and to understand how to leverage the blockchain technology underlying bitcoin.
- Healthcare – The proliferation of networked medical devices as part of the IoT is targeting cost reduction—a key issue for the industry—as well as patient efficacy.
- Manufacturing – With the development of intelligent devices—from aircraft engines to appliances—manufacturers are reimagining their customer relationships, supply chains and business models.
- Retail – Retail firms—online and offline—are using software to change the way they interact with and engage customers, from offering promotions on smartphones to enhancing inventory transparency.
Given the importance of cloud, mobility and analytics for compiling and transmitting customer and partner information, software’s importance will increase—across all segments. The companies that best leverage software to incorporate industry knowledge with technology savvy will thrive.
What to watch for
While the cloud continues to underpin massive change, software vendors must determine what to buy, what to own and with whom to partner—and the partnership environment is percolating. While we’re already seeing some unexpected joint ventures between long-established corporations and startups, many companies that seek to use software for a competitive advantage may find the choices to be overwhelming.
“In the future, there will be no hardware without software, and software will become artificial intelligence,” says Chitkara. “Software will continue to be central to the fast pace of change—not only in the technology sector, but across all industries.”
About the Global 100 Software Leaders
This is the fourth edition of PwC’s Global 100 Software Leaders ranking since 2010. The current edition continues our tradition of monitoring and analysing the leading companies and trends in the industry. Our goal is to help our clients understand both the obvious and the underlying forces influencing the software industry.
The new PwC Global 100 Software Leaders list is based on corporate financial statements (GAAP-based where applicable), other public sources and estimates for privately held companies, as compiled for PwC by the Global Software Business Strategies Group at IDC. Learn more about the report’s methodology here.
The initial article provides an overview of the trends impacting the global leaders and others. Future articles will examine issues impacting the fastest growing cloud-based companies and the larger software companies in emerging markets.
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 157 countries with more than 208,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.
©2016 PricewaterhouseCoopers. All rights reserved
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
Nicholas Braude, PwC
Tel: (617) 530-5435
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 201817.7.2018 22:30 | Pressemelding
LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the meeting, all resolutions for which management recommended a vote in favor, were adopted, including: - Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2017 and quietus of directors; - Allocation of the financial year's results; - Approval of regulatory agreements and commitments referred to in Article L.225-38 of the French Commercial Code; - Approval of the regulations of the share subscription and/or purchase options plan adopted by the Board of Directors on June 27, 2017; - Authorization for the Board of Directors to grant share subscription and/or share purchase options and/or to issue detachable share subscription warrants to corporate officers and employees of the Company or companies in the ERYTECH Pharma
Williams Scotsman Receives Competition Bureau Clearance for ModSpace Acquisition17.7.2018 22:15 | Pressemelding
BALTIMORE, July 17, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (NASDAQ:WSC) ("Williams Scotsman"), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that, on July 16, 2018, the Canadian Competition Bureau issued a No Action Letter relating to Williams Scotsman's proposed acquisition of Modular Space Corporation ("ModSpace"). WillScot has now obtained the regulatory approvals required to complete the acquisition and continues to progress towards closing in the third quarter of 2018. About Williams Scotsman Headquartered in Baltimore, Maryland, WillScot Corporation is the public holding company for the Williams Scotsman family of companies in the United States, Canada and Mexico. WillScot Corporation trades on the NASDAQ stock exchange under the ticker symbol "WSC." Williams Scotsman is a specialty rental services market leader providing innovative modular space and portable storage solutio
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors17.7.2018 22:05 | Pressemelding
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the election of Jeryl Hilleman to the Board of Directors of the Company. "Jeri brings a broad life sciences background to Minerva that includes high growth commercial biopharma, med-tech and data science companies," said William F. Doyle, Lead Independent Director of Minerva. "Her track record of delivering strategic and financial growth through execution, strategic partnering and multiple acquisitions will serve Minerva well as the Company completes five ongoing late-stage clinical trials with roluperidone, seltorexant and MIN-117." Ms. Hilleman is presently Chief Financial Officer of Intersect ENT (NASDAQ:XENT), a medical device company with commercial products for the treatment of chronic sinusitis. Previously, she served as CFO of several public
Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide17.7.2018 21:00 | Pressemelding
OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a grant of $2M US dollars by the National Center for Research and Development . The grant will fund a project to advance development of the company's innovative microbicide candidate (OB-002H). Designed to prevent the transmission of HIV, OB-002H has the potential to address an urgent and growing need for an HIV prevention product that is affordable, appealing to use, and easily integrates into the lifestyles of people at risk for HIV infection regardless of age, sex or gender. The project is co-financed by the National Center for Research and Development under the InnoNeuroPharm program - Measure 1.2: Sectoral R & D programs of the Intelligent Development Operational Program 2014-2020. Orion Biotechnology will use the grant to complete IND enabling studies, advance OB-002H to
Greater Anglia Selects PowerPlan to Optimise Its Asset Investments17.7.2018 15:29 | Pressemelding
ATLANTA, July 17, 2018 (GLOBE NEWSWIRE) -- Greater Anglia, a UK-based train operating company, has selected PowerPlan's Asset Investment Optimization software suite to maximise its asset investments over a 40-year time period. Greater Anglia's long-term investment strategy includes a 40-year asset plan to meet its regulatory requirements. For what was historically built with manual processes and not easily tracked, the Asset Investment Optimization solution from PowerPlan will provide a comprehensive, auditable approach to help the company analyze different investment scenarios for impacts to risk, cost, timing and level of service and provide a defendable asset plan for the next four decades. "The condition of our assets drives our business," said Richard Turner, Head of Asset Management for Greater Anglia. "With PowerPlan, we can apply a fact-based methodology to prioritise investments, maximise their return and produce plans that communicate our asset strategy to internal and extern
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 201817.7.2018 14:30 | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 9268558, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com. The replay will be available on the Company's website for approximately
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom